South Korean CRO MediCROstar Joins Medidata Solutions' Channel Partner Program
Medidata Solutions
announced that South Korean contract research organization (CRO)
MediCROstar
has joined Medidata’s channel partner program for CROs and other service providers. In addition to bringing the capabilities of the
Medidata Rave
electronic data capture (EDC) and clinical data management (CDM) solution, the partnership will enable MediCROstar to further expand its presence in the APAC region and continue to build its stake in the global clinical trials marketplace.
Founded in 2006, Seoul-based MediCROstar specializes in electronic case report format (eCRF) data management and protocol development for investigator-initiated trials. With experience managing clinical trials across South Korea and India, MediCROstar executives helped the Korea Food and Drug Administration (KFDA) write formal guidance on conducting EDC trials. As a result, the company has become a player in South Korea’s clinical development as the growth in clinical trials in the region has driven increasing need for technologies as well as outsourcing organizations to help efficiently manage the studies. MediCROstar looks to the Medidata partner program as a key driver of its global expansion and is developing new services around Medidata Rave to offer customers the efficient data management, local language capabilities and ease of use of the proven Rave platform.
“The adoption of EDC technology is a growing trend in South Korea, mirroring its use in the global pharmaceutical industry, and we have looked to Medidata’s partner program to help us field the increasing demand for innovative clinical technologies,” said Inyoung Choi, director, MediCROstar.
MediCROstar expects to leverage the Medidata Rave solution for a number of Phase III global multinational trials over the next year.
On September 10th, Medidata and MediCROstar will co-host a seminar titled “Safe Transfer – From Paper CRF to eCRF” at EL Tower, 24 Yangjae-dong, Seocho-gu, Seoul, South Korea. The seminar will outline the sponsor and CRO benefits of the Medidata Rave solution and introduce trends of data management in Korea. Presenters include Dong-Seok Yim, MediCROstar CEO, and Takeru Yamamoto, head of APAC at Medidata Solutions. For more information, please visit:
www.medicrostar.com
Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include over 25 partners. For more information, please visit:
www.mdsol.com/partnerships/cros.htm
.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
